Wzy-dependent bacterial capsules as potential drug targets
Ericsson, Daniel J., Standish, Alistair, Kobe, Bostjan and Morona, Renata (2012) Wzy-dependent bacterial capsules as potential drug targets. Current Drug Targets, 1311: 1421-1431.
The bacterial capsule is a recognized virulence factor in pathogenic bacteria. It likely works as an anti-phagocytic barrier by minimizing complement deposition on the bacterial surface. With the continual rise of bacterial pathogens resistant to multiple antibiotics, there is an increasing need for novel drugs. In the Wzy-dependent pathway, the biosynthesis of capsular polysaccharide (CPS) is regulated by a phosphoregulatory system, whose main components consist of bacterial-tyrosine kinases (BY-kinases) and their cognate phosphatases. The ability to regulate capsule biosynthesis has been shown to be vital for pathogenicity, because different stages of infection require a shift in capsule thickness, making the phosphoregulatory proteins suitable as drug targets. Here, we review the role of regulatory proteins focusing on Streptococcus pneumoniae, Staphylococcus aureus, and Escherichia coli and discuss their suitability as targets in structure-based drug design.